Taigen Biotechnology Co., Ltd.
Records under this name other than the patents Taigen Biotechnology Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 6 patents it holds.
Back to Taigen Biotechnology Co., Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,158,798 | Coupling Process for Preparing Quinolone Intermediates Formerly held In force · High confidence | In force | High confidence | |
| US 7,589,197 | Pyrimidine compounds Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,193,206 | Pyrimidine compounds Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,372,849 | Heterocyclic compounds Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,023,834 | Lyophilization Formulation Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,375,406 | Substituted pyrimidines for mobilizing cells expressing a type 4 CXC chemokine receptor Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,639,349 | Stereoselective Synthesis of Intermediate for Preparation of Heterocyclic Compound Formerly held In force · High confidence | In force | High confidence | |
| US 11,872,224 | Amorphous Solid Dispersion Formulation Formerly held In force · High confidence | In force | High confidence | |
| US 10,004,719 | Solid Dispersion Formulation Lapsed on the fee record Ended Jun 26, 2026 · High confidence | Lapsed on the fee record | Ended Jun 26, 2026 | High confidence |
| US 8,658,183 | Antimicrobial parenteral formulation Lapsed on the fee record Ended Feb 25, 2026 · USPTO record | Lapsed on the fee record | Ended Feb 25, 2026 | USPTO record |